CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Planned sale Chief Executive Officer sold 79,712 shares at $5.95 ($474,239)
- 144 Insider Sale of Securities
- 4 Planned sale EVP and General Counsel sold 7,373 shares at $9.14 ($67,402)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 4 Planned sale Director sold 10,056 shares at $9.45 ($95,063)
- 4 Planned sale EVP & Chief Technology Officer sold 14,168 shares at $9.45 ($133,936)
- 4 Grant or award EVP & Chief Financial Officer acquired 40,000 shares (grant or award)
- 4 Grant or award EVP and Chief Medical Officer acquired 40,000 shares (grant or award)
- 4 Planned sale SVP, Chief Accounting Officer sold 1,562 shares at $9.45 ($14,766)
- 4 Planned sale Chief Executive Officer sold 16,122 shares at $9.45 ($152,408)
- 4 Planned sale EVP and General Counsel sold 5,140 shares at $9.45 ($48,590)
- 144 Insider Sale of Securities
Page 9 of 41 · 806 filings